{"id":1042640,"date":"2010-06-30T08:19:13","date_gmt":"2010-06-30T08:19:13","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/progress-in-viral-cancer-therapy\/"},"modified":"2024-08-17T16:58:59","modified_gmt":"2024-08-17T20:58:59","slug":"progress-in-viral-cancer-therapy","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/longevity-medicine\/progress-in-viral-cancer-therapy.php","title":{"rendered":"Progress in Viral Cancer Therapy"},"content":{"rendered":"<p><a href=\"http:\/\/www.scientificamerican.com\/article.cfm\">Scientific American<\/a> looks at the state of <a href=\"http:\/\/www.fightaging.org\/archives\/2006\/10\/stomping-on-cancer-with-viruses.php\">viral cancer therapies<\/a>: \"The adapted virus that immunized hundreds of millions of people against smallpox has now been enlisted in the war on cancer. <a href=\"http:\/\/en.wikipedia.org\/wiki\/Poxviridae\">Vaccinia poxvirus<\/a> joins a <a href=\"http:\/\/en.wikipedia.org\/wiki\/Herpesviridae\">herpesvirus<\/a> and a host of other <a href=\"http:\/\/en.wikipedia.org\/wiki\/Pathogen\">pathogens<\/a> on a growing list of engineered viruses entering late-stage human testing against cancer. ... After a decade of development of so-called oncolytic viruses, the newest strains hold the most promise yet ... In a two-pronged attack, these viruses specifically target tumor cells while delivering a cargo of immune-boosting genes. In contrast, viruses that cause cancer, such as the human <a href=\"http:\/\/en.wikipedia.org\/wiki\/Papillomaviridae\">papillomavirus<\/a> that is responsible for most cases of cervical cancer, disrupt a cell's <a href=\"http:\/\/en.wikipedia.org\/wiki\/Genome\">genome<\/a>, thereby triggering out-of-control growth. When the engineered viruses recognize and infect cancer cells, they replicate and sometimes destroy their hosts. Several of the viruses also release the gene for <a href=\"http:\/\/en.wikipedia.org\/wiki\/Granulocyte_macrophage_colony-stimulating_factor\">granulocyte-macrophage colony-stimulating factor (GM-CSF)<\/a> an <a href=\"http:\/\/en.wikipedia.org\/wiki\/Immune_system\">immune system<\/a> protein. The GM-CSF attracts a swarm of <a href=\"http:\/\/en.wikipedia.org\/wiki\/White_blood_cell\">white blood cells<\/a> and other immune system operatives that mount a further attack on the tumor. ... The vaccinia virus has been developed by the biotechnology company <a href=\"http:\/\/www.jennerex.com\" \/>Jennerex<\/a> ... Later this year, the company plans to launch a <a href=\"http:\/\/en.wikipedia.org\/wiki\/Clinical_trial\">phase III clinical trial<\/a> in advanced liver cancer patients, in which the virus will be added to standard <a href=\"http:\/\/en.wikipedia.org\/wiki\/Antibody\">antibody<\/a> treatment.\"<\/p>\n<p>View the Article Under Discussion: <a href=\"http:\/\/www.scientificamerican.com\/article.cfm\">http:\/\/www.scientificamerican.com\/article.cfm?id=tumor-virus-vaccines<\/a><br \/>\n<br \/>Read More Longevity Meme Commentary: <a href=\"http:\/\/www.longevitymeme.org\/news\" \/>http:\/\/www.longevitymeme.org\/news\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Scientific American looks at the state of viral cancer therapies: \"The adapted virus that immunized hundreds of millions of people against smallpox has now been enlisted in the war on cancer. Vaccinia poxvirus joins a herpesvirus and a host of &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/longevity-medicine\/progress-in-viral-cancer-therapy.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246678],"tags":[],"class_list":["post-1042640","post","type-post","status-publish","format-standard","hentry","category-longevity-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1042640"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1042640"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1042640\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1042640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1042640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1042640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}